-
1 Comment
Aster DM Healthcare Limited is currently in a long term uptrend where the price is trading 0.7% above its 200 day moving average.
From a valuation standpoint, the stock is 83.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Aster DM Healthcare Limited's total revenue sank by 2.7% to $23B since the same quarter in the previous year.
Its net income has dropped by 33.6% to $924M since the same quarter in the previous year.
Finally, its free cash flow grew by 11.0% to $7B since the same quarter in the previous year.
Based on the above factors, Aster DM Healthcare Limited gets an overall score of 3/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
ISIN | INE914M01019 |
Sector | Healthcare |
Industry | Medical Care Facilities |
PE Ratio | 129.15 |
---|---|
Target Price | 576.6667 |
Dividend Yield | 1.5% |
Beta | 0.23 |
Market Cap | 275B |
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ASTERDM.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025